03/20/2020
7:30 AM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2020
7:01 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/16/2020
6:57 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/16/2020
6:52 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2020
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2020
3:54 PM | 10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:09 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:05 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:05 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:05 PM | AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:02 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:02 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:01 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
4:58 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
4:56 PM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
4:55 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2019
8:01 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2019
8:26 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2019
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
9:01 AM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
6:54 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
6:52 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2019
7:00 AM | Galectin Therapeutics (Filer)
| Form DEF 14A
| |
10/15/2019
5:56 AM | 10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2019
7:30 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2019
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2019
2:00 PM | AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
12:30 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
11:15 PM | Galectin Therapeutics (Filer)
| Form EFFECT
| |
08/09/2019
3:32 PM | Galectin Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/09/2019
6:59 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
6:53 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2019
5:03 AM | 10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
12:13 PM | 10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
5:10 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4/A
| |
06/03/2019
4:45 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
4:42 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
4:31 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
4:29 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
4:29 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
4:28 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
7:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
7:02 AM | Galectin Therapeutics (Subject)
| Form FWP
| |
05/10/2019
6:59 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
6:56 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
6:52 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2019
2:13 PM | Galectin Therapeutics (Filer)
| Form 424B1
| |
04/15/2019
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2019
11:16 PM | Galectin Therapeutics (Filer)
| Form EFFECT
| |
04/12/2019
8:01 AM | Galectin Therapeutics (Filer)
| Form S-3/A
| |
04/09/2019
3:02 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2019
3:46 PM | Galectin Therapeutics (Filer)
| Form S-3/A
| |
04/08/2019
3:32 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2019
3:31 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2019
3:30 PM | Galectin Therapeutics (Subject)
Uihlein Richard E (Filed by)
| Form SC 13D/A
| |
04/08/2019
3:30 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2019
7:45 AM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
04/01/2019
5:02 PM | 10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
04/01/2019
4:59 PM | 10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
3:37 PM | 10X Fund, L.P. (Filed by)
Galectin Therapeutics (Subject)
| Form SC 13D/A
| |
03/21/2019
4:00 PM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2019
4:17 PM | Galectin Therapeutics (Filer)
| Form S-3/A
| |
03/06/2019
6:58 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2019
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2019
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2019
6:53 AM | Galectin Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/06/2019
6:53 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2019
3:38 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2019
3:30 PM | AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
9:55 AM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4/A
| |
01/30/2019
4:31 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2019
4:31 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
5:23 PM | AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2019
3:31 PM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2019
4:20 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:20 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:20 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:19 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:19 PM | Galectin Therapeutics (Issuer)
SHULMAN STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:18 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:18 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:17 PM | AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:17 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:16 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
4:16 PM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
7:30 AM | Galectin Therapeutics (Filer)
| Form 8-K/A
| |
12/20/2018
7:25 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/28/2018
3:32 PM | Galectin Therapeutics (Filer)
| Form 10-Q/A
| |
09/28/2018
3:31 PM | Galectin Therapeutics (Filer)
| Form 10-K/A
| |
09/26/2018
6:59 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2018
11:28 AM | Galectin Therapeutics (Filer)
| Form 424B3
| |
09/20/2018
6:51 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2018
3:06 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
11:15 PM | Galectin Therapeutics (Filer)
| Form EFFECT
| |
09/06/2018
3:24 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2018
3:08 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
